Primary Category:
Treatment Protocols
Disease Category:
Gastrointestinal, Small Bowel
Status:
Open
Randomized Phase II Selection Study of Ramucirumab and Paclitaxel Versus FOLFIRI in Refractory Small Bowel Adenocarcinoma
NCT#04205968
Primary Category:
Treatment Protocols
Disease Category:
Gastrointestinal, Small Bowel
Status:
Open
Randomized Phase II Selection Study of Ramucirumab and Paclitaxel Versus FOLFIRI in Refractory Small Bowel Adenocarcinoma
NCT#04205968